Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | -0.66% | -7.58% | +5.87% |
07/05 | Inozyme Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/04 | Transcript : Inozyme Pharma, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.87% | 28Cr | |
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+43.51% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- Wedbush Adjusts Price Target for Inozyme Pharma to $23 From $25, Maintains Outperform Rating